Metformin glycinate clinical trials
Also written DMMET-01.
How each study uses metformin glycinate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
9 studies that test it; most in 2021 (2)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2020 | 1 |
| 2021 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 9 · Other 0
Studies
Open first, then newest update. How each study uses metformin glycinate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 9
- Efficacy and Safety of Metformin Glycinate Compared to Metformin Hydrochloride on the Progression of Type 2 DiabetesSuspendedPhase 3Laboratorios Silanes S.A. de C.V.NCT04943692Written as Metformin glycinateHow we know
- Metformin Glycinate, Treatment of Patients With COVID-19 and Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2.CompletedPhase 2Laboratorios Silanes S.A. de C.V.NCT04625985Written as Metformin GlycinateHow we know
- Metformin Glycinate in Patients With MS or DM2 , Hospitalized With COVID-19 and SARS Secondary to SARS-CoV-2WithdrawnPhase 2Laboratorios Silanes S.A. de C.V.NCT04626089Written as metformin glycinateHow we know
- Gastric Tolerability and Pharmacokinetics of DMMET-01CompletedPhase 1Laboratorios Silanes S.A. de C.V.NCT00960882Written as DMMET-01How we know
- Clinical Trial to Evaluate Safety and pK Profile of Metformin Glycinate in Healthy VolunteersCompletedPhase 1Laboratorios Silanes S.A. de C.V.NCT01560481Written as Step A: metformin glycinate 620 mg single doseHow we know
- Metformin Glycinate on Metabolic Control and Inflammatory Mediators in Type 2 DiabetesCompletedPhase 3Laboratorios Silanes S.A. de C.V.NCT01386671Written as Metformin glycinateHow we know
- Efficacy Study of Metformin Glycinate on Postprandial LipemiaStatus unknownPhase 2/3Laboratorios Silanes S.A. de C.V.NCT02064881Written as Metformin glycinateHow we know
- Study on DMMET-01 Versus Metformin on Improvement of Metabolic Control in Naive Type 2 Diabetes PatientsCompletedPhase 2/3Laboratorios Silanes S.A. de C.V.NCT00940472Written as DMMET-01How we know
- Effect of DMMET-01 on Insulin Sensitivity in Naive Type 2 Diabetes Patients (CLAMP)CompletedPhase 2Laboratorios Silanes S.A. de C.V.NCT00940797Written as DMMET-01How we know
Codes
What other systems call metformin glycinate · ClinicalTrials.gg INT018587
- UNII (FDA) YEI21W005YMETFORMIN GLYCINATEConfirmed FDA, Wikidata
- Wikidata Q27294486metformin glycinateConfirmed FDA, Wikidata
- NCI Thesaurus C170168Metformin GlycinateOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | YEI21W005Y | METFORMIN GLYCINATE | Confirmed FDA, Wikidata |
| Wikidata | Q27294486 | metformin glycinate | Confirmed FDA, Wikidata |
| NCI Thesaurus | C170168 | Metformin Glycinate | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.